These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15123119)

  • 61. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.
    Baay MF; Smits E; Tjalma WA; Lardon F; Weyler J; Van Royen P; Van Marck EA; Vermorken JB
    Int J Cancer; 2004 Jan; 108(2):258-61. PubMed ID: 14639612
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Tobacco smoking and HPV infection].
    Maciejewska J; Walentowicz M; Bodnar M; Grabiec M; Marszałek A
    Przegl Lek; 2010; 67(10):847-9. PubMed ID: 21360912
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [HPV-tests as suitable complement to cytological screening].
    Rubinstein E
    Lakartidningen; 1999 May; 96(18):2195. PubMed ID: 10377654
    [No Abstract]   [Full Text] [Related]  

  • 64. Patient safety and the next generation of HPV DNA tests.
    Simon K; Kondratovich MV; Hojvat S; Gutierrez A
    Am J Clin Pathol; 2011 May; 135(5):798-9; author reply 799-803. PubMed ID: 21502437
    [No Abstract]   [Full Text] [Related]  

  • 65. New HPV test now recommended.
    AIDS Patient Care STDS; 2003 Dec; 17(12):671-2. PubMed ID: 14748367
    [No Abstract]   [Full Text] [Related]  

  • 66. [Self-sampling at home can prevent cervix cancer].
    Sanner K; Wikström I; Lindell M; Strand A; Wilander E
    Lakartidningen; 2009 Nov 11-17; 106(46):3075-7. PubMed ID: 19998610
    [No Abstract]   [Full Text] [Related]  

  • 67. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies.
    Gage JC; Ajenifuja KO; Wentzensen NA; Adepiti AC; Eklund C; Reilly M; Hutchinson M; Wacholder S; Harford J; Soliman AS; Burk RD; Schiffman M
    Int J Cancer; 2012 May; 130(9):2111-7. PubMed ID: 21630264
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
    Sookaromdee P; Wiwanitkit V
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S1020-S1021. PubMed ID: 38384106
    [No Abstract]   [Full Text] [Related]  

  • 69. [Human papillomavirus testing. Important to differ between screening and diagnostics].
    Fomsgaard A
    Ugeskr Laeger; 2002 Mar; 164(13):1831; author reply 1831. PubMed ID: 11957447
    [No Abstract]   [Full Text] [Related]  

  • 70. A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care.
    Badman SG; Vallely AJ; Pardo C; Mhango LP; Cornall AM; Kaldor JK; Whiley D
    Pathology; 2021 Feb; 53(2):264-266. PubMed ID: 33358758
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence of the human papillomavirus in an inner-city indigent population with previously normal Pap tests.
    Werden J; Schnatz PF; Mandavilli S; Allen G; Murphy JL; Greene JF; Egan JF; Sorosky JI
    J Low Genit Tract Dis; 2008 Oct; 12(4):287-92. PubMed ID: 18820543
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The HPV test in cervical screening: a brave new world?
    Desai MS; Cubie HA
    Cytopathology; 2005 Feb; 16(1):3-6. PubMed ID: 15859308
    [No Abstract]   [Full Text] [Related]  

  • 73. A morphological protocol and guide-list on uterine cervix cytology associated to Papillomavirus infection.
    Yamamoto LS; Alves VA; Maeda MY; Longatto-Filho A; Utagawa ML; Eluf Neto J
    Rev Inst Med Trop Sao Paulo; 2004; 46(4):189-93. PubMed ID: 15361969
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human papillomavirus DNA testing as an adjunct in primary screening: is it prime time?
    Zahn CM
    Obstet Gynecol; 2004 Apr; 103(4):617-8. PubMed ID: 15051549
    [No Abstract]   [Full Text] [Related]  

  • 75. [HPV infection in etiology of uterine cervix cancer].
    Olejek A
    Ginekol Pol; 2008 Feb; 79(2):126-32. PubMed ID: 18510092
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Efficient cytologic screening: selective and in combination with HPV test].
    Rubinstein E
    Lakartidningen; 2000 Jan; 97(4):371. PubMed ID: 10684236
    [No Abstract]   [Full Text] [Related]  

  • 77. Is it true that pre-conization high-risk HPV DNA load is a significant factor of persistence of HPV infection after conization?
    Broccolo F; Fusetti L; Ceccherini-Nelli L
    J Clin Virol; 2012 Dec; 55(4):377-8. PubMed ID: 22921516
    [No Abstract]   [Full Text] [Related]  

  • 78. A population-based study on the risks of cervical lesion and human papillomavirus infection among women in Beijing, People's Republic of China.
    Li C; Wu M; Wang J; Zhang S; Zhu L; Pan J; Zhang W
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2655-64. PubMed ID: 20719907
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospective study of HPV DNA in cervical specimens from women with renal transplants.
    Fairley CK; Chen S; Tabrizi SN; Walker R; Atkins RC; Garland SM
    Nephrol Dial Transplant; 1994; 9(10):1520-1. PubMed ID: 7816274
    [No Abstract]   [Full Text] [Related]  

  • 80. New way to detect cervical cancer.
    Can Nurse; 2001 May; 97(5):10. PubMed ID: 11865599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.